0.2
2022CiteScore
 
37th percentile
Powered by  Scopus
Image description
Maciej Dzik, Grzegorz Binowski, Piotr Chłosta, Jakub Dobruch, Paweł Miotła, Tomasz Rechberger, Adam Bierut, Maciej Jesionowski

Economic analysis of Noqturina® (oral lyophilisate) use in the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria

Keywords: nocturia, costs, falls, pharmacoeconomics, 1-deamino-8-D-arganine-vasopressin

Read More
Image description
Image description
Magdalena Piekarska, Damian Swieczkowski, Tomasz Haręźlak, Jerzy Krysiński, Natalia Cwalina, Szymon Zdanowski, Miłosz Jarosław Jaguszewski, Piotr Merks

The combination of angiotensin converting enzyme inhibitors, diuretics and non-steroidal anti-inflammatory drugs in the routine community pharmacy settings in Poland: The unrecognized problem of ‘Triple Whammy’. A pilot analysis.

Keywords: Triple Whammy; drug-related problem; clinical pharmacy; pharmaceutical care; community pharmacy; prescribing cascade; pharmacist

Read More
Image description
Image description
Jennifer L Gill, Panos G Kanavos

RWE in Europe – An Analysis

Keywords: Patient relevant outcomes, Real world data, Regulation, Market access, Real world evidence

Read More
Image description
Image description
Ewa Kamińska, Iwona Dobrowolska, Alicja Wójcik, Katarzyna Młyńczak, Joanna Lis, Marta Dąbrowska, Beata Wójtowicz, Anna Smolarska, Anna Gora, Maciej Niewada, Dominik Golicki

Major Cardiovascular Consequences of Familial Hypercholesterolemia in Poland from the Economic Perspective

Keywords: stroke, hypercholesterolemia, cost of illness, myocardial infarction, peripheral arterial disease

Read More
Image description
Image description
Łukasz Kaczyński, Dariusz Pawlik, Beata Serafin, Rafał Wójcik, Marcin Kaczor, Joanna Lis, Ewelina Bernaszuk, Katarzyna Wepsięć

VaxigripTetra (Quadrivalent Influenza Vaccine) – evidence for clinical and economic benefits from vaccination in population aged 65 and over in Poland

Keywords: elderly, influenza, vaccination, VaxigripTetra, quadrivalent influenza vaccine, cost-effectiveness

Read More
Image description
Image description
Ewa Borowiack, Magdalena Marzec, Anna Nowotarska, Katarzyna Policht, Katarzyna Snarska, Małgorzata Konopka-Pliszka, Joanna Jarosz, Monika Borowiack

Cost-utility analysis and budget impact analysis of pegvisomant for the treatment of adult patients with acromegaly in Poland

Keywords: pegvisomant, adult, acromegaly, economic

Read More
Image description
Image description
Malwina Holownia, Ilya Solodun, Ekaterina Bashlakova, Tatiana Ermolaeva, Maria Davydovskaya, Evgeniy Evdoshenko

Cost-effectiveness analysis of methods of diagnosis of tb infection in russian regions by use of recombinant tb allergen in children and adolescents.

Keywords: diagnostics, diaskintest, recombinant tuberculosis allergen, tuberculosis, cost-effectiveness analysis

Read More
Image description
Image description
Damian Świeczkowski, Piotr Merks, Natalia Cwalina, Milosz Jaguszewski

Patients' opinions on metoprolol, as expressed on the Internet - an exploratory, qualitative study

Keywords: quality use of medicines; Internet; qualitative study; Poland; patient safety

Read More
Image description
Image description
Agnieszka Michalczewska, Grzegorz Wallner

Nutritional management in patients with gastrointestinal tumors in the surgical department

Keywords: clinical nutrition, cachexia, gastrointestinal cancers, malnutrition

Read More
Image description

Journal of Health Policy & Outcomes Research

ISSN 2299-1247

Journal of Health Policy & Outcomes Research (JHPOR) is a peer-reviewed, international scientific journal, covering health policy, pharmacoeconomics and outcomes research in Poland and worldwide. The journal is issued under the auspices of the Polish Society of Pharmacoeconomics. It is published twice a year in electronic form, optionally in the paper version. All of the articles are published under the Open Access model. Our goal is to facilitate communication between researchers and health care policy makers by offering an outlet for discussion and dialogue. Our Journal is indexed in various databases such as Google Scholar, Index Copernicus (ICV 2020= 100) or BazEkon. It has also been given a score of 40 points by Ministry of Education and Science Republic of Poland. Since October 2022, JHPOR is also indexed in Scopus database.

JHPOR’s scope includes following topics:

Newsletter

Subscribe to our newsletter:

Journal of Health Policy & Outcomes Research (JHPOR) is a peer-reviewed, international scientific journal, covering health policy, pharmacoeconomics and outcomes research in Poland and worldwide. The journal is issued under the auspices of the Polish Society of Pharmacoeconomics. It is published twice a year in electronic form, optionally in the paper version. From 2019, we publish articles in the "volume open" system. Our goal is to facilitate communication between researchers and health care policy makers by offering an outlet for discussion and dialogue. Our journal is published by Pro Medicina Foundation (Fundacja Pro Medicina). All of the articles are published under the Open Access model. No fees are charged for reading any of our articles.

Editorial Board

Meet all the experts comprising our Editorial Board, Editorial Advisory Board and Reviewers

Contact us
Image description DEPUTY EDITOR-IN-CHIEF

JOANNA LIS

PHD Medical University of Warsaw, Sanofi Group


Image description EDITOR-IN-CHIEF

PROF. KARINA JAHNZ-RÓŻYK, MD, PHD

Military Institute of Medicine


Image description DEPUTY EDITOR-IN-CHIEF

MONIKA SZKULTECKA-DĘBEK, MD, PHD


Join us

Become a part of a leading international, peer-reviewed scientific journal in Central and Eastern Europe.
Join Us

About Us

Journal of Health Policy & Outcomes Research (JHPOR) is a peer-reviewed, international scientific journal, covering health policy, pharmacoeconomics and outcomes research in Poland and worldwide. The journal is issued under the auspices of the Polish Society of Pharmacoeconomics.

Subscribe to our newsletter:

Latest Articles

Our Contacts

Fundacja PRO MEDICINA
Śliska 3 lok. 55
00-127 Warszawa
NIP 5252390463
REGON 140936540
KRS 0000277843

2017 © Pro Medicina Foundation